Primary testicular diffuse large B-cell lymphoma belongs to the nongerminal center B-cell-like subgroup: a study of 18 cases

[1]  K. Ribeiro,et al.  BCL2 Expression Is a Prognostic Marker for the Activated B-Cell-Like Type of Diffuse Large B-Cell Lymphoma. , 2006 .

[2]  J. Sparano,et al.  AIDS and non-AIDS diffuse large B-cell lymphomas express different antigen profiles , 2006, Modern Pathology.

[3]  T. Habermann,et al.  Adult B-Cell Lymphomas With Burkitt-Like Morphology Are Phenotypically and Genotypically Heterogeneous With Aggressive Clinical Behavior , 2005, The American journal of surgical pathology.

[4]  S. Takenoshita,et al.  Primary breast diffuse large B-cell lymphoma shows a non-germinal center B-cell phenotype , 2005, Modern Pathology.

[5]  G. Ott,et al.  Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis , 2005, The Journal of pathology.

[6]  S. Rosso,et al.  Population-based incidence and mortality cancer trends (1986–1997) from the network of Italian cancer registries , 2004, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[7]  J. Teruya-Feldstein,et al.  Primary follicular lymphoma of the testis: excellent outcome following surgical resection without adjuvant chemotherapy. , 2004, Journal of pediatric hematology/oncology.

[8]  S. Rosso,et al.  Cancer trends in Italy: figures from the cancer registries (1986-1997). , 2004, Epidemiologia e prevenzione.

[9]  Gruppo Italiano Screening del Cervicocarcinoma GISCi.  [Recommendations for quality control of cervico-vaginal cytology]. , 2004, Epidemiologia e prevenzione.

[10]  L. Staudt,et al.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. , 2004, Blood.

[11]  J. Coebergh,et al.  Trends in incidence of and mortality from cancer in The Netherlands in the period 1989-1998. , 2003, European journal of cancer.

[12]  S. Kvaløy,et al.  Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  F. Cavalli,et al.  Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Emili Montserrat,et al.  Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. , 2003, Blood.

[15]  P. Colombat,et al.  Stage I-IIE primary non-Hodgkin's lymphoma of the testis: results of a prospective trial by the GOELAMS Study Group. , 2002, Clinical lymphoma.

[16]  S. Pileri,et al.  Primary follicular lymphoma of the testis in childhood: an entity with peculiar clinical and molecular characteristics , 2002, Journal of clinical pathology.

[17]  W. Yang,et al.  CD10 expression in primary intestinal large B-cell lymphomas: its clinical significance. , 2002, Archives of pathology & laboratory medicine.

[18]  G. MacLennan,et al.  Follicular large cell lymphoma localized to the testis in children. , 2002, The Journal of urology.

[19]  S. Barrans,et al.  Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma. , 2002, Blood.

[20]  Meland,et al.  The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.

[21]  L. Medeiros,et al.  Primary follicular large cell lymphoma of the testis in a child. , 2009, Archives of pathology & laboratory medicine.

[22]  A. Ramaioli,et al.  Non-Hodgkin's lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centres. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  H. Prince,et al.  Primary large-cell non-Hodgkin's lymphoma of the testis: a retrospective analysis of patterns of failure and prognostic factors. , 2001, Clinical lymphoma.

[24]  K. Molberg,et al.  Clinicopathologic analysis of CD10+ and CD10- diffuse large B-cell lymphoma. Identification of a high-risk subset with coexpression of CD10 and bcl-2. , 2001, American journal of clinical pathology.

[25]  K. Ohshima,et al.  CD10 and Bcl10 expression in diffuse large B‐cell lymphoma: CD10 is a marker of improved prognosis , 2001, Histopathology.

[26]  Yasodha Natkunam,et al.  Analysis of MUM1/IRF4 Protein Expression Using Tissue Microarrays and Immunohistochemistry , 2001, Modern Pathology.

[27]  C. Ross,et al.  The clinical significance of CD10 antigen expression in diffuse large B-cell lymphoma. , 2001, American journal of clinical pathology.

[28]  Kazumi Suzuki,et al.  Primary testicular plasmacytoma with hydrocele of the testis , 2001, International journal of urology : official journal of the Japanese Urological Association.

[29]  L. Larocca,et al.  Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. , 2001, Blood.

[30]  A. Iwashita,et al.  Histologic and Immunohistologic Findings and Prognosis of 40 Cases of Gastric Large B-Cell Lymphoma , 2000, The American journal of surgical pathology.

[31]  T. Naab,et al.  Testicular Plasmacytoma in a Patient with the Acquired Immunodeficiency Syndrome , 2000, Tumori.

[32]  H. Ohno,et al.  Nonimmunoglobulin (non-Ig)/BCL6gene fusion in diffuse large B-cell lymphoma results in worse prognosis than Ig/BCL6 , 2000 .

[33]  P. Isaacson,et al.  CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. , 2000, The American journal of surgical pathology.

[34]  G. Gaidano,et al.  MUM1: a step ahead toward the understanding of lymphoma histogenesis , 2000, Leukemia.

[35]  I. Hanamura,et al.  MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies , 2000, Leukemia.

[36]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[37]  H. Ohno,et al.  Nonimmunoglobulin (non-Ig)/BCL6 gene fusion in diffuse large B-cell lymphoma results in worse prognosis than Ig/BCL6. , 2000, Blood.

[38]  K. Ohshima,et al.  Prognostic clinicopathologic factors, including immunologic expression in diffuse large B‐cell lymphomas , 1999, Pathology international.

[39]  H. Kwon,et al.  Interferon regulatory factors: the next generation. , 1999, Gene.

[40]  B. Szende,et al.  A case of bilateral testicular lymphoma , 1999, Pathology & Oncology Research.

[41]  J C Reed,et al.  Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. , 1997, Blood.

[42]  W. Wilson,et al.  Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas. , 1997, Blood.

[43]  S. Pileri,et al.  Bcl-6 protein expression in normal and neoplastic lymphoid tissues. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[44]  D C Linch,et al.  Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study. , 1996, Blood.

[45]  R S Chaganti,et al.  BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[46]  J. Libertino,et al.  Bilateral primary non-Hodgkin's lymphoma of the testis. , 1996, Urology.

[47]  G. Magoha.  Bilateral primary malignant lymphoma of the testis: case report. , 1996, East African medical journal.

[48]  J Diebold,et al.  Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA). , 1996, Blood.

[49]  K. Offit,et al.  BCL-6 protein is expressed in germinal-center B cells. , 1995, Blood.

[50]  N. Harris,et al.  Malignant Lymphoma of the Testis, Epididymis, and Spermatic Cord: A Clinicopathologic Study of 69 Cases with Immunophenotypic Analysis , 1994, The American journal of surgical pathology.

[51]  S. Mushtaq,et al.  Non-Hodgkin's lymphomas with primary manifestation in gonads--a clinicopathological study. , 1994, JPMA. The Journal of the Pakistan Medical Association.

[52]  A. Moreau,et al.  Testicular tumor and the acquired immunodeficiency syndrome. , 1994, European urology.

[53]  A. Crellin,et al.  Non-Hodgkin's lymphoma of the testis. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[54]  C. McKiel,et al.  Acquired immunodeficiency syndrome presenting as testicular lymphoma. , 1992, The Journal of urology.

[55]  A. Sagalowsky,et al.  Testicular tumors in men with human immunodeficiency virus. , 1992, The Journal of urology.

[56]  S. Swan,et al.  Temporal trends in the incidence of non-Hodgkin's lymphoma and selected malignancies in a population with a high incidence of acquired immunodeficiency syndrome (AIDS) , 1988, American journal of epidemiology.